PG
AMED

PEAK6 Group’s Amedisys AMED Stock Holding History

PEAK6 Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$479K Buy
+5,600
New +$411K ﹤0.01% 2632
2017
Q4 		– Sell
-10,300
Closed -$576K – 4051
2017
Q3 		$576K Buy
10,300
+1,100
+12% +$58.2K ﹤0.01% 2438
2017
Q2 		$578K Buy
+9,200
New +$536K ﹤0.01% 2408
2017
Q1 		– Sell
-1,400
Closed -$60K – 4245
2016
Q4 		$60K Sell
1,400
-16,900
-92% -$719K ﹤0.01% 4125
2016
Q3 		$868K Buy
18,300
+1,700
+10% +$84.8K 0.01% 1895
2016
Q2 		$838K Buy
16,600
+10,200
+159% +$515K 0.01% 1940
2016
Q1 		$309K Sell
6,400
-6,100
-49% -$235K ﹤0.01% 2723
2015
Q4 		$492K Sell
12,500
-10,000
-44% -$400K ﹤0.01% 2610
2015
Q3 		$854K Sell
22,500
-152,000
-87% -$6.41M ﹤0.01% 2360
2015
Q2 		$6.93M Buy
174,500
+162,000
+1,296% +$5.05M 0.04% 637
2015
Q1 		$335K Sell
12,500
-10,300
-45% -$291K ﹤0.01% 2964
2014
Q4 		$669K Buy
22,800
+10,300
+82% +$254K 0.01% 2309
2014
Q3 		$252K Sell
12,500
-17,100
-58% -$330K ﹤0.01% 3098
2014
Q2 		$496K Buy
+29,600
New +$419K ﹤0.01% 2322
2014
Q1 		– Sell
-15,300
Closed -$224K – 4821
2013
Q4 		$224K Sell
15,300
-158,900
-91% -$2.56M ﹤0.01% 3429
2013
Q3 		$1.5M Buy
+174,200
New +$2.58M 0.01% 1794

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PEAK6 Group's AMED Position: Q3 2017 in Review

PEAK6 Group sold out of Amedisys (AMED) in Q3 2017, closing a stake of 2,558 shares — an estimated $135K sold.

PEAK6 Group first reported a position in AMED in Q3 2013 and held it in 3 quarters. The position peaked at $550K in Q4 2016. 163 funds tracked by Wall St. Rank hold AMED as of Q3 2017.

  • PEAK6 Group reported no remaining Amedisys position as of Q3 2017 after selling out during the quarter.
  • PEAK6 Group sold 2,558 Amedisys shares in Q3 2017, an estimated $135K.
  • PEAK6 Group first reported a position in Amedisys in Q3 2013 and held it in 3 quarters.
  • PEAK6 Group's Amedisys position peaked at $550K in Q4 2016.
  • 163 funds tracked by Wall St. Rank held Amedisys as of Q3 2017.

Based on PEAK6 Group's 13F filing for Q3 2017, filed 14 Nov 2017.